Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.855 USD | +3.08% | +3.85% | -6.86% |
Apr. 02 | Voyager Therapeutics, Inc. Appoints Robin Swartz as Principal Accounting Officer | CI |
Apr. 02 | Voyager Therapeutics, Inc. Announces CFO Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.86% | 414M | |
+2.68% | 42.75B | |
+48.20% | 41.61B | |
+12.27% | 41.34B | |
-12.36% | 26.59B | |
+8.51% | 25.49B | |
-23.86% | 18.12B | |
+30.61% | 12.24B | |
-1.84% | 11.76B | |
+7.59% | 11B |
- Stock Market
- Equities
- VYGR Stock
- News Voyager Therapeutics, Inc.
- Wedbush Trims Voyager Therapeutics' Price Target to $10 From $11, Neutral Rating Kept